Patent | Date |
---|
Proteasome Activity Enhancing Compounds App 20220298181 - Cullen; Matthew ;   et al. | 2022-09-22 |
Compounds, Compositions, And Methods For Modulating Cftr App 20220227739 - Munoz; Benito ;   et al. | 2022-07-21 |
Methods Of Treating Pulmonary Diseases And Disorders App 20220175735 - Miller; John ;   et al. | 2022-06-09 |
Compounds, compositions, and methods for modulating CFTR Grant 11,248,010 - Munoz , et al. February 15, 2 | 2022-02-15 |
Proteasome activity enhancing compounds Grant 11,242,361 - Cullen , et al. February 8, 2 | 2022-02-08 |
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20210369749 - Parks; Daniel ;   et al. | 2021-12-02 |
Compounds, compositions, and methods for modulating CFTR Grant 11,136,313 - Munoz , et al. October 5, 2 | 2021-10-05 |
Compounds, compositions, and methods for increasing CFTR activity Grant 11,098,035 - Bastos , et al. August 24, 2 | 2021-08-24 |
Compounds, compositions, and methods of increasing CFTR activity Grant 11,083,709 - Munoz , et al. August 10, 2 | 2021-08-10 |
Proteasome Activity Enhancing Compounds App 20210115057 - Cullen; Matthew ;   et al. | 2021-04-22 |
Compounds, Compositions, And Methods For Modulating Cftr App 20210061823 - Munoz; Benito ;   et al. | 2021-03-04 |
Compounds, compositions, and methods for increasing CFTR activity Grant 10,899,751 - Parks , et al. January 26, 2 | 2021-01-26 |
Compounds, Compositions, And Methods For Modulating Cftr App 20200385365 - Munoz; Benito ;   et al. | 2020-12-10 |
Compounds, Compositions, And Methods Of Increasing Cftr Activity App 20200360348 - Munoz; Benito ;   et al. | 2020-11-19 |
Proteasome Activity Enhancing Compounds App 20200308198 - Cullen; Matthew ;   et al. | 2020-10-01 |
Compounds, compositions, and methods for increasing CFTR activity Grant 10,738,040 - Bastos , et al. A | 2020-08-11 |
Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis Grant 10,738,011 - Bastos , et al. A | 2020-08-11 |
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20200190072 - Bastos; Cecilia M. ;   et al. | 2020-06-18 |
Compounds, compositions, and methods for modulating CFTR Grant 10,662,207 - Munoz , et al. | 2020-05-26 |
Compounds, compositions, and methods for modulating CFTR Grant 10,550,106 - Munoz , et al. Fe | 2020-02-04 |
Compounds, compositions, and methods of increasing CFTR activity Grant 10,548,878 - Munoz , et al. Fe | 2020-02-04 |
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20200010461 - Parks; Daniel ;   et al. | 2020-01-09 |
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20190308960 - Bastos; Cecilia M. ;   et al. | 2019-10-10 |
Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis Grant 10,392,378 - Bastos , et al. A | 2019-08-27 |
Compounds, compositions, and methods for increasing CFTR activity Grant 10,392,372 - Bastos , et al. A | 2019-08-27 |
Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis Grant 10,344,023 - Bastos , et al. July 9, 2 | 2019-07-09 |
Compounds, Compositions, And Methods For Modulating Cftr App 20190153000 - Munoz; Benito ;   et al. | 2019-05-23 |
Compounds, compositions, and methods for increasing CFTR activity Grant 10,174,014 - Bastos , et al. J | 2019-01-08 |
Methods Of Treating Pulmonary Diseases And Disorders App 20180369209 - Miller; John ;   et al. | 2018-12-27 |
Derivatives Of 5-(hetero)arylpyrazol-3-carboxylic Amide Or 1-(hetero)aryltriazol-4-carboxylic Amide Useful For The Treatment Of Inter Alia Cystic Fibrosis App 20180327363 - Bastos; Cecilia M. ;   et al. | 2018-11-15 |
Compounds, Compositions, And Methods For Modulating Cftr App 20180291006 - Munoz; Benito ;   et al. | 2018-10-11 |
Proteasome Activity Enhancing Compounds App 20180282352 - Cullen; Matthew ;   et al. | 2018-10-04 |
Compounds, Compositions, And Methods Of Increasing Cftr Activity App 20180214419 - Munoz; Benito ;   et al. | 2018-08-02 |
Compounds, compositions, and methods for increasing CFTR activity Grant 10,017,503 - Bastos , et al. July 10, 2 | 2018-07-10 |
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20180147187 - Bastos; Cecilia M. ;   et al. | 2018-05-31 |
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20180127400 - Bastos; Cecilia M. ;   et al. | 2018-05-10 |
2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors App 20180093981 - Siegel; Craig ;   et al. | 2018-04-05 |
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20170369480 - Bastos; Cecilia M. ;   et al. | 2017-12-28 |
Derivatives Of 5-phenyl- Or 5-heteroarylathiazol-2-carboxylic Amide Useful For The Treatment Of Inter Alia Cystic Fibrosis App 20170369482 - Bastos; Cecilia M. ;   et al. | 2017-12-28 |
Proteasome activity enhancing compounds Grant 9,850,262 - Cullen , et al. December 26, 2 | 2017-12-26 |
Derivatives Of 3-heteroarylisoxazol-5-carboxylic Amide Useful For The Treatment Of Inter Alia Cystic Fibrosis App 20170362214 - Bastos; Cecilia M. ;   et al. | 2017-12-21 |
Compounds, compositions, and methods for increasing CFTR activity Grant 9,790,219 - Bastos , et al. October 17, 2 | 2017-10-17 |
2-acylaminopropoanol-type glucosylceramide synthase inhibitors Grant 9,744,153 - Siegel , et al. August 29, 2 | 2017-08-29 |
2-acylaminopropoanol-type glucosylceramide synthase inhibitors Grant 9,745,294 - Siegel , et al. August 29, 2 | 2017-08-29 |
Compounds, compositions, and methods for increasing CFTR activity Grant 9,745,292 - Bastos , et al. August 29, 2 | 2017-08-29 |
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20170233379 - Bastos; Cecilia M. ;   et al. | 2017-08-17 |
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20170001993 - Bastos; Cecilia M. ;   et al. | 2017-01-05 |
Compounds, Compositions, And Methods For Increasing Cftr Activity App 20170001991 - Bastos; Cecilia M. ;   et al. | 2017-01-05 |
2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors App 20160338996 - Siegel; Craig ;   et al. | 2016-11-24 |
Proteasome Activity Enhancing Compounds App 20160333031 - Cullen; Matthew ;   et al. | 2016-11-17 |
2-acylaminopropoanol-type glucosylceramide synthase inhibitors Grant 9,272,996 - Siegel , et al. March 1, 2 | 2016-03-01 |
2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors App 20150225393 - Siegel; Craig ;   et al. | 2015-08-13 |
2-acylaminopropoanol-type glucosylceramide synthase inhibitors Grant 8,940,776 - Siegel , et al. January 27, 2 | 2015-01-27 |
2-acylaminopropoanol-type Glucosylceramide Synthase Inhibitors App 20120322786 - Siegel; Craig ;   et al. | 2012-12-20 |
2-acylaminopropoanol-type Glucosylceramide Synthase Inhibitors App 20120322787 - Siegel; Craig ;   et al. | 2012-12-20 |
2-acylaminopropoanol-type glucosylceramide synthase inhibitors Grant 8,309,593 - Siegel , et al. November 13, 2 | 2012-11-13 |
2-acylaminopropoanol-type glucosylceramide synthase inhibitors Grant 8,304,447 - Siegel , et al. November 6, 2 | 2012-11-06 |
2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors App 20110184021 - Siegel; Craig ;   et al. | 2011-07-28 |
2-acylaminopropoanol-type Glucosylceramide Synthase Inhibitors App 20100256216 - Siegel; Craig ;   et al. | 2010-10-07 |
Phosphate transport inhibitors Grant 7,754,200 - Jozefiak , et al. July 13, 2 | 2010-07-13 |
Phosphate transport inhibitors App 20070021509 - Jozefiak; Thomas H. ;   et al. | 2007-01-25 |
Phosphate transport inhibitors App 20060280719 - Jozefiak; Thomas H. ;   et al. | 2006-12-14 |
Phosphate transport inhibitors Grant 7,119,120 - Jozefiak , et al. October 10, 2 | 2006-10-10 |
Phosphate transport inhibitors Grant 7,109,184 - Jozefiak , et al. September 19, 2 | 2006-09-19 |
Phosphate transport inhibitors App 20040019113 - Jozefiak, Thomas H. ;   et al. | 2004-01-29 |
Phosphate transport inhibitors App 20040019020 - Jozefiak, Thomas H. ;   et al. | 2004-01-29 |
Method for inhibiting immune response Grant 5,708,022 - Bastos , et al. January 13, 1 | 1998-01-13 |